Overview
Zimmer Biomet Holdings, Inc., based in the United States, specializes in the design, manufacture, and marketing of orthopedic reconstructive products, sports medicine, biologics, extremities and trauma products, office-based technologies, spine, craniomaxillofacial, and thoracic products, dental implants, and related surgical products. As a leader in the medical devices sector, the company focuses heavily on musculoskeletal healthcare. Zimmer Biomet is renowned for its innovative solutions that enhance patient outcomes in hospitals and clinics worldwide. Key projects involve the development of technologies that improve the precision and recovery times of orthopedic surgeries, alongside significant investments in robotics and data analytics to optimize surgical efficiency and patient care. These initiatives underscore Zimmer Biomet's commitment to advancing healthcare through cutting-edge medical technology.
Basic Stats
The share price of Zimmer Biomet Holdings, Inc. as of September 5, 2025 is $105.69 / share. This is a decrease of -0.39% from the prior week. The market cap (or net worth) of Zimmer Biomet Holdings, Inc. as of September 5, 2025 is $20,916.05 MM.
The Factor Analysis chart (below right) shows a view of Zimmer Biomet Holdings, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 20,916.05 MM |
| EV | 27,940.95 MM |
| Shares Out. | 197.90 MM |
| Earnings Date | |
| EPS (TTM) | 4.16 |
| Dividend Yield | 0.91 % |
| Ex-Dividend Date | 2025-09-30 |
| Borrow Rate | 0.25 |
| Short Shares Avail. | 1.70 MM |
| Short Interest | 6.96 MM |
| Short Float | 3.52 % |
| Days to Cover | 8.15 days |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | 1.17 % |
| Volatility (1 yr) | 0.26 |
| Beta | 0.35 |
| Sharpe Ratio (1 yr) | -0.11 |
| Sortino Ratio (1 yr) | -0.17 |
| PE Ratio | 25.40 |
| Price/Book | 1.67 |
| Price/TBV | -10.12 |
| Book/Market | 0.60 |
| EBIT/EV | 0.03 |
| EBIT(3yr avg)/EV | 0.03 |
| ROA | 0.04 |
| ROE | 0.06 |
| ROIC | 0.04 |
| CROIC | 0.01 |
| OCROIC | 0.08 |
| Implied Volatility | 21.64 % |
| Put/Call OI Ratio | 1.17 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Zimmer Biomet Holdings, Inc. is $114.12. The forecasts range from a low of $96.96 to a high of $147.00. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Zimmer Biomet Holdings, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-01-03 | Evercore ISI Group | Outperform | In-Line | Downgrade |
| 2023-01-09 | RBC Capital | Sector Perform | Outperform | Upgrade |
| 2023-01-06 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-01-05 | Raymond James | Market Perform | Outperform | Upgrade |
| 2023-01-11 | JP Morgan | Neutral | Maintains | |
| 2022-02-08 | Deutsche Bank | Hold | Maintains | |
| 2022-12-20 | Truist Securities | Hold | Maintains | |
| 2022-12-12 | Citigroup | Neutral | Maintains | |
| 2022-11-23 | Wells Fargo | Underweight | Equal-Weight | Upgrade |
| 2022-11-03 | RBC Capital | Sector Perform | Maintains | |
| 2022-11-03 | Citigroup | Neutral | Maintains | |
| 2022-10-18 | Barclays | Underweight | Initiate | |
| 2022-10-12 | Jefferies | Underperform | Initiate | |
| 2022-08-03 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-07-18 | Stifel | Buy | Maintains | |
| 2022-07-15 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-05-27 | Needham | Buy | Hold | Downgrade |
| 2022-05-17 | Citigroup | Neutral | Maintains | |
| 2022-05-04 | SVB Leerink | Outperform | Maintains | |
| 2022-05-04 | RBC Capital | Sector Perform | Maintains | |
| 2022-03-21 | Goldman Sachs | Buy | Maintains | |
| 2022-03-02 | Loop Capital | Buy | Hold | Downgrade |
| 2022-02-09 | Loop Capital | Buy | Maintains | |
| 2022-02-08 | Wells Fargo | Underweight | Maintains | |
| 2022-02-08 | Truist Securities | Buy | Maintains | |
| 2022-02-08 | SVB Leerink | Outperform | Maintains | |
| 2022-02-08 | RBC Capital | Sector Perform | Maintains | |
| 2022-02-08 | Needham | Buy | Maintains | |
| 2022-02-08 | JMP Securities | Market Outperform | Maintains | |
| 2022-02-08 | Canaccord Genuity | Buy | Hold | Downgrade |
| 2022-02-02 | UBS | Buy | Neutral | Downgrade |
| 2022-01-21 | Needham | Buy | Maintains | |
| 2022-01-19 | Wells Fargo | Overweight | Underweight | Downgrade |
| 2022-01-10 | BTIG | Buy | Neutral | Downgrade |
| 2022-01-07 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2022-01-04 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2021-12-21 | Truist Securities | Buy | Maintains | |
| 2021-12-10 | RBC Capital | Sector Perform | Initiate | |
| 2021-12-09 | Needham | Strong Buy | Buy | Downgrade |
| 2021-12-07 | Loop Capital | Buy | Initiate | |
| 2021-11-23 | Argus Research | Buy | Hold | Downgrade |
| 2021-11-05 | JMP Securities | Market Outperform | Maintains | |
| 2021-11-05 | Jefferies | Buy | Maintains | |
| 2021-10-05 | Barclays | Overweight | Maintains | |
| 2021-08-04 | SVB Leerink | Outperform | Maintains | |
| 2021-08-04 | Oppenheimer | Outperform | Maintains | |
| 2021-08-04 | Canaccord Genuity | Buy | Maintains | |
| 2021-05-25 | Barclays | Overweight | Initiate | |
| 2021-05-11 | JMP Securities | Market Outperform | Maintains | |
| 2021-05-05 | SVB Leerink | Outperform | Maintains | |
| 2021-05-05 | Raymond James | Strong Buy | Maintains | |
| 2021-05-05 | Canaccord Genuity | Buy | Maintains | |
| 2021-04-09 | Northland Capital Markets | Market Perform | Outperform | Upgrade |
| 2021-03-01 | Wells Fargo | Overweight | Maintains | |
| 2021-02-08 | SVB Leerink | Outperform | Maintains | |
| 2021-02-08 | Raymond James | Strong Buy | Maintains | |
| 2021-02-08 | Morgan Stanley | Overweight | Maintains | |
| 2021-02-08 | Deutsche Bank | Hold | Maintains | |
| 2021-02-05 | Needham | Strong Buy | Maintains | |
| 2021-01-27 | JMP Securities | Market Outperform | Maintains | |
| 2021-01-25 | BTIG | Buy | Maintains | |
| 2021-01-04 | Evercore ISI Group | In-Line | Outperform | Upgrade |
| 2020-12-15 | Morgan Stanley | Overweight | Maintains | |
| 2020-12-14 | SVB Leerink | Outperform | Maintains | |
| 2020-11-09 | SVB Leerink | Outperform | Maintains | |
| 2020-11-09 | Credit Suisse | Underperform | Maintains | |
| 2020-10-20 | Northland Capital Markets | Market Perform | Initiate | |
| 2020-10-12 | Raymond James | Strong Buy | Maintains | |
| 2020-10-05 | SVB Leerink | Outperform | Maintains | |
| 2020-09-11 | Wolfe Research | Outperform | Initiate | |
| 2020-08-05 | SVB Leerink | Outperform | Maintains | |
| 2020-08-05 | Raymond James | Strong Buy | Maintains | |
| 2020-08-05 | Needham | Strong Buy | Maintains | |
| 2020-08-05 | Morgan Stanley | Overweight | Maintains | |
| 2020-07-15 | SVB Leerink | Outperform | Maintains | |
| 2020-05-18 | JMP Securities | Market Outperform | Maintains | |
| 2020-05-12 | Wells Fargo | Overweight | Maintains | |
| 2020-05-12 | UBS | Buy | Maintains | |
| 2020-05-12 | SVB Leerink | Outperform | Maintains | |
| 2020-05-12 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2020-05-12 | Stifel | Buy | Maintains | |
| 2020-05-12 | Raymond James | Strong Buy | Maintains | |
| 2020-05-12 | Oppenheimer | Outperform | Maintains | |
| 2020-05-12 | Deutsche Bank | Hold | Maintains | |
| 2020-05-12 | Citigroup | Buy | Maintains | |
| 2020-05-12 | Canaccord Genuity | Buy | Maintains | |
| 2020-05-11 | Needham | Strong Buy | Maintains | |
| 2020-04-28 | Guggenheim | Buy | Neutral | Downgrade |
| 2020-04-13 | Raymond James | Strong Buy | Maintains | |
| 2020-04-09 | Evercore ISI Group | Outperform | In-Line | Downgrade |
| 2020-04-07 | SVB Leerink | Outperform | Maintains | |
| 2020-04-07 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2020-04-07 | Needham | Strong Buy | Maintains | |
| 2020-04-07 | BTIG | Buy | Maintains | |
| 2020-03-27 | Morgan Stanley | Overweight | Maintains | |
| 2020-03-27 | Citigroup | Buy | Maintains | |
| 2020-03-24 | Stifel | Buy | Maintains | |
| 2020-03-06 | Credit Suisse | Underperform | Maintains | |
| 2020-03-05 | Citigroup | Buy | Initiate | |
| 2020-02-13 | Goldman Sachs | Buy | Initiate | |
| 2020-02-05 | Raymond James | Strong Buy | Maintains | |
| 2020-02-05 | Morgan Stanley | Overweight | Maintains | |
| 2020-02-05 | Deutsche Bank | Hold | Maintains | |
| 2020-02-05 | Credit Suisse | Underperform | Maintains | |
| 2020-02-05 | Baird | Outperform | Maintains | |
| 2020-02-04 | Needham | Strong Buy | Reiterate | |
| 2020-01-10 | Wells Fargo | Overweight | Maintains | |
| 2020-01-08 | SunTrust Robinson Humphrey | Buy | Initiate | |
| 2020-01-07 | Piper Sandler | Neutral | Overweight | Upgrade |
| 2019-12-19 | Needham | Strong Buy | Maintains | |
| 2019-12-17 | Morgan Stanley | Overweight | Maintains | |
| 2019-12-04 | Raymond James | Outperform | Strong Buy | Upgrade |
| 2019-11-06 | UBS | Buy | Maintains | |
| 2019-11-06 | RBC Capital | Outperform | Maintains | |
| 2019-11-06 | Raymond James | Outperform | Maintains | |
| 2019-10-07 | BTIG | Neutral | Buy | Upgrade |
| 2019-09-18 | Canaccord Genuity | Hold | Buy | Upgrade |
| 2019-09-09 | Wells Fargo | Outperform | Maintains | |
| 2019-08-12 | Argus | Hold | Buy | Upgrade |
| 2019-08-02 | Citi | Buy | Maintains | |
| 2019-07-30 | Barclays | Underweight | Equal-Weight | Upgrade |
| 2019-07-29 | Wells Fargo | Outperform | Maintains | |
| 2019-07-29 | Raymond James | Outperform | Maintains | |
| 2019-07-29 | Morgan Stanley | Overweight | Maintains | |
| 2019-07-29 | Baird | Neutral | Outperform | Upgrade |
| 2019-06-11 | Bernstein | Underperform | Market Perform | Upgrade |
| 2019-04-24 | Needham | Buy | Strong Buy | Upgrade |
| 2019-04-15 | Barclays | Underweight | Underweight | Maintains |
| 2019-04-08 | Evercore ISI Group | In-Line | Outperform | Upgrade |
| 2019-03-04 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2019-01-03 | Deutsche Bank | Hold | Initiate | |
| 2019-01-02 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2019-01-02 | Citigroup | Neutral | Buy | Upgrade |
| 2018-12-19 | JP Morgan | Overweight | Neutral | Downgrade |
| 2018-12-18 | Credit Suisse | Underperform | Initiate | |
| 2018-11-28 | UBS | Buy | Initiate | |
| 2018-10-29 | Jefferies | Buy | Buy | Maintains |
| 2018-10-29 | Citigroup | Neutral | Neutral | Maintains |
| 2018-10-29 | Barclays | Underweight | Underweight | Maintains |
| 2018-10-16 | Barclays | Underweight | Initiate | |
| 2018-10-11 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-08-16 | BTIG Research | Neutral | Initiate | |
| 2018-08-13 | Needham | Strong Buy | Buy | Downgrade |
| 2018-07-31 | Citigroup | Neutral | Neutral | Maintains |
| 2018-07-30 | Raymond James | Outperform | Outperform | Maintains |
| 2018-07-30 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2018-07-30 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2018-07-30 | Canaccord Genuity | Hold | Hold | Maintains |
| 2018-07-30 | Baird | Neutral | Neutral | Maintains |
| 2018-06-27 | Bernstein | Underperform | Initiate | |
| 2018-06-22 | Argus | Buy | Hold | Downgrade |
| 2018-04-27 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-04-27 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2018-04-03 | Evercore ISI Group | In-Line | Initiate | |
| 2018-03-23 | Baird | Outperform | Neutral | Downgrade |
| 2018-03-15 | Raymond James | Outperform | Initiate | |
| 2018-02-28 | Citigroup | Neutral | Neutral | Maintains |
| 2018-02-27 | Citigroup | Neutral | Neutral | Maintains |
| 2018-02-26 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-01-31 | Stifel Nicolaus | Hold | Buy | Upgrade |
| 2018-01-31 | Leerink Swann | Outperform | Outperform | Maintains |
| 2017-12-20 | Goldman Sachs | Sell | Neutral | Upgrade |
| 2017-11-14 | Deutsche Bank | Hold | Buy | Upgrade |
| 2017-11-09 | Edward Jones | Hold | Buy | Upgrade |
| 2017-11-02 | PiperJaffray | Overweight | Neutral | Downgrade |
| 2017-11-02 | Morgan Stanley | Overweight | Maintains | |
| 2017-11-02 | BMO Capital | Outperform | Maintains | |
| 2017-08-24 | Gabelli & Co. | Buy | Initiate | |
| 2017-07-28 | Leerink Swann | Outperform | Maintains | |
| 2017-07-28 | Canaccord Genuity | Buy | Hold | Downgrade |
| 2017-07-28 | BMO Capital | Outperform | Maintains | |
| 2017-07-17 | Morgan Stanley | Overweight | Maintains | |
| 2017-07-12 | Guggenheim | Neutral | Buy | Upgrade |
| 2017-06-30 | Cantor Fitzgerald | Neutral | Initiate | |
| 2017-05-16 | Goldman Sachs | Sell | Initiate | |
| 2017-04-28 | Wells Fargo | Outperform | Market Perform | Downgrade |
| 2016-12-15 | UBS | Neutral | Sell | Downgrade |
| 2016-11-08 | Northcoast Research | Buy | Neutral | Downgrade |
| 2016-11-01 | Needham | Buy | Strong Buy | Upgrade |
| 2016-08-23 | Barclays | Overweight | Maintains | |
| 2016-08-11 | SunTrust Robinson Humphrey | Buy | Initiate | |
| 2016-08-02 | UBS | Neutral | Maintains | |
| 2016-07-29 | JP Morgan | Overweight | Maintains | |
| 2016-07-29 | JMP Securities | Market Outperform | Maintains | |
| 2016-07-29 | Jefferies | Buy | Maintains | |
| 2016-07-29 | Citigroup | Sell | Maintains | |
| 2016-07-29 | Barclays | Overweight | Maintains | |
| 2016-06-09 | Guggenheim | Neutral | Initiate | |
| 2016-05-25 | Argus | Buy | Upgrade | |
| 2016-05-02 | Leerink Swann | Outperform | Maintains | |
| 2016-03-17 | Nomura | Buy | Initiate | |
| 2016-03-04 | Argus | Buy | Hold | Downgrade |
| 2016-01-29 | Credit Suisse | Outperform | Maintains | |
| 2016-01-27 | JMP Securities | Market Outperform | Maintains | |
| 2016-01-07 | Northland Securities | Outperform | Market Perform | Downgrade |
| 2015-11-12 | Citigroup | Sell | Initiate | |
| 2015-11-04 | Sterne Agee CRT | Buy | Initiate | |
| 2015-07-08 | Goldman Sachs | Neutral | Initiate | |
| 2023-02-06 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-02-06 | Truist Securities | Hold | Maintains | |
| 2023-02-06 | Oppenheimer | Outperform | Maintains | |
| 2023-02-07 | JMP Securities | Market Outperform | Reiterate | |
| 2023-03-10 | Piper Sandler | Neutral | Overweight | Upgrade |
| 2023-03-29 | UBS | Sell | Initiate | |
| 2023-03-31 | Jefferies | Underperform | Hold | Upgrade |
| 2023-04-11 | Evercore ISI Group | In-Line | Outperform | Upgrade |
| 2023-05-03 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-05-03 | B of A Securities | Underperform | Neutral | Upgrade |
| 2023-05-03 | RBC Capital | Outperform | Maintains | |
| 2023-05-03 | Baird | Outperform | Maintains | |
| 2023-05-03 | Raymond James | Outperform | Maintains | |
| 2023-05-03 | Bernstein | Market Perform | Maintains | |
| 2023-05-03 | JMP Securities | Outperform | Maintains | |
| 2023-05-03 | Truist Securities | Hold | Maintains | |
| 2023-05-03 | Citigroup | Neutral | Maintains | |
| 2023-05-31 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-05-18 | Stifel | Buy | Buy | Maintains |
| 2023-05-18 | Truist Securities | Hold | Hold | Maintains |
| 2023-05-04 | Barclays | Underweight | Maintains | |
| 2023-12-04 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-06-28 | Baird | Outperform | Outperform | Reiterate |
| 2023-11-09 | Raymond James | Outperform | Outperform | Maintains |
| 2023-11-13 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2024-02-09 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-02-09 | Truist Securities | Hold | Hold | Maintains |
| 2023-12-22 | Truist Securities | Hold | Hold | Maintains |
| 2023-10-20 | Roth MKM | Neutral | Initiate | |
| 2024-05-17 | Needham | Hold | Reiterate | |
| 2023-08-28 | BTIG | Neutral | Buy | Upgrade |
| 2023-08-02 | Morgan Stanley | Equal-Weight | Equal-Weight | Reiterate |
| 2023-08-02 | Truist Securities | Hold | Hold | Maintains |
| 2023-08-02 | JMP Securities | Market Outperform | Market Outperform | Reiterate |
| 2023-08-02 | Oppenheimer | Outperform | Outperform | Reiterate |
| 2023-08-02 | Barclays | Underweight | Underweight | Maintains |
| 2023-10-02 | Citigroup | Neutral | Neutral | Maintains |
| 2023-07-19 | Truist Securities | Hold | Hold | Maintains |
| 2023-11-08 | JP Morgan | Neutral | Neutral | Maintains |
| 2023-11-08 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-01-04 | Evercore ISI Group | Outperform | In-Line | Downgrade |
| 2024-02-09 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-02-23 | Canaccord Genuity | Hold | Hold | Reiterate |
| 2024-05-31 | Barclays | Underweight | Underweight | Maintains |
| 2024-02-12 | Barclays | Underweight | Underweight | Maintains |
| 2024-05-02 | Needham | Hold | Reiterate | |
| 2024-04-04 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-01-12 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-01-03 | Raymond James | Outperform | Outperform | Maintains |
| 2024-05-30 | Goldman Sachs | Neutral | Initiate | |
| 2024-05-30 | Needham | Hold | Reiterate | |
| 2024-05-21 | Argus Research | Hold | Buy | Upgrade |
| 2024-04-03 | Citigroup | Neutral | Neutral | Maintains |
| 2024-05-03 | Truist Securities | Hold | Hold | Maintains |
| 2024-05-03 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-07-01 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2024-07-02 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-07-15 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-07-10 | Citigroup | Neutral | Neutral | Maintains |
| 2024-07-16 | Truist Securities | Hold | Hold | Maintains |
| 2024-10-31 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-10-31 | Needham | Hold | Reiterate | |
| 2025-01-23 | Stifel | Buy | Buy | Maintains |
| 2024-08-08 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-09-06 | TD Cowen | Hold | Hold | Maintains |
| 2024-12-12 | Barclays | Underweight | Underweight | Maintains |
| 2024-10-08 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-08-08 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-12-17 | JP Morgan | Neutral | Overweight | Upgrade |
| 2024-09-10 | Canaccord Genuity | Hold | Hold | Maintains |
| 2024-08-08 | Baird | Outperform | Outperform | Maintains |
| 2024-08-08 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-08-08 | Needham | Hold | Reiterate | |
| 2024-08-08 | UBS | Sell | Sell | Maintains |
| 2024-08-08 | Raymond James | Outperform | Outperform | Maintains |
| 2024-10-03 | BTIG | Buy | Buy | Maintains |
| 2025-02-07 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-02-07 | JMP Securities | Market Outperform | Market Outperform | Reiterate |
| 2025-02-07 | Raymond James | Outperform | Outperform | Maintains |
| 2025-02-07 | Needham | Hold | Hold | Reiterate |
| 2024-12-18 | Truist Securities | Hold | Hold | Maintains |
| 2024-09-17 | Needham | Hold | Reiterate | |
| 2024-09-16 | JP Morgan | Neutral | Neutral | Maintains |
| 2025-01-29 | Needham | Hold | Hold | Reiterate |
| 2024-11-01 | Truist Securities | Hold | Hold | Maintains |
| 2025-05-07 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2025-02-10 | Truist Securities | Hold | Hold | Reiterate |
| 2025-02-10 | Barclays | Underweight | Underweight | Maintains |
| 2024-09-13 | Truist Securities | Hold | Hold | Reiterate |
| 2024-09-05 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-09-05 | Truist Securities | Hold | Hold | Maintains |
| 2024-10-15 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-10-14 | Raymond James | Outperform | Outperform | Maintains |
| 2024-08-20 | Canaccord Genuity | Hold | Hold | Maintains |
| 2024-10-01 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-11-04 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-09-10 | Wolfe Research | Peer Perform | Initiate | |
| 2025-08-08 | Raymond James | Outperform | Outperform | Maintains |
| 2025-08-08 | UBS | Sell | Sell | Maintains |
| 2025-08-08 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-05-12 | Canaccord Genuity | Hold | Hold | Maintains |
| 2025-05-06 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-05-06 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-05-06 | Stifel | Buy | Buy | Maintains |
| 2025-05-06 | Raymond James | Outperform | Outperform | Maintains |
| 2025-05-06 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2025-05-06 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-05-06 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-05-06 | Baird | Outperform | Outperform | Maintains |
| 2025-07-08 | Evercore ISI Group | In-Line | In-Line | Maintains |
